Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Palvella Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 09:39 am Purchase | 2025-03-31 | 13G | Palvella Therapeutics, Inc. PVLA | Frazier Life Sciences Public Fund, L.P. | 690,012 6.300% | 114,120 (+19.82%) | Filing |
| 2025-01-08 3:04 pm Purchase | 2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA | Frazier Life Sciences Public Fund, L.P. | 575,892 5.100% | 575,892 (New Position) | Filing |